Jeremy G Chadwick - Net Worth and Insider Trading
Jeremy G Chadwick Net Worth
The estimated net worth of Jeremy G Chadwick is at least $2 Million dollars as of 2024-11-05. Jeremy G Chadwick is the COO of Kymera Therapeutics Inc and owns about 44,183 shares of Kymera Therapeutics Inc (KYMR) stock worth over $2 Million. Details can be seen in Jeremy G Chadwick's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeremy G Chadwick has not made any transactions after 2024-05-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeremy G Chadwick
Jeremy G Chadwick Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeremy G Chadwick owns 2 companies in total, including Madrigal Pharmaceuticals Inc (MDGL) , and Kymera Therapeutics Inc (KYMR) .
Click here to see the complete history of Jeremy G Chadwick’s form 4 insider trades.
Insider Ownership Summary of Jeremy G Chadwick
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MDGL | Madrigal Pharmaceuticals Inc | 2007-02-05 | Sr. VP & Program Mgmt and Ops |
KYMR | Kymera Therapeutics Inc | 2024-05-23 | Chief Operating Officer |
Jeremy G Chadwick Latest Holdings Summary
Jeremy G Chadwick currently owns a total of 1 stock. Jeremy G Chadwick owns 44,183 shares of Kymera Therapeutics Inc (KYMR) as of May 23, 2024, with a value of $2 Million.
Latest Holdings of Jeremy G Chadwick
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KYMR | Kymera Therapeutics Inc | 2024-05-23 | 44,183 | 47.17 | 2,084,112 |
Holding Weightings of Jeremy G Chadwick
Jeremy G Chadwick Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeremy G Chadwick has made a total of 1 transactions in Kymera Therapeutics Inc (KYMR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Kymera Therapeutics Inc is the sale of 2,575 shares on May 23, 2024, which brought Jeremy G Chadwick around $90,099.
Insider Trading History of Jeremy G Chadwick
- 1
Jeremy G Chadwick Trading Performance
Jeremy G Chadwick Ownership Network
Ownership Network List of Jeremy G Chadwick
Ownership Network Relation of Jeremy G Chadwick
Jeremy G Chadwick Owned Company Details
What does Madrigal Pharmaceuticals Inc do?
Who are the key executives at Madrigal Pharmaceuticals Inc?
Jeremy G Chadwick is the Sr. VP & Program Mgmt and Ops of Madrigal Pharmaceuticals Inc. Other key executives at Madrigal Pharmaceuticals Inc include director & President and CEO William John Sibold , Senior VP & Chief Pharma Dev. Robert E. Waltermire , and director & 10 percent owner Fred B Craves .
Madrigal Pharmaceuticals Inc (MDGL) Insider Trades Summary
Over the past 18 months, Jeremy G Chadwick made no insider transaction in Madrigal Pharmaceuticals Inc (MDGL). Other recent insider transactions involving Madrigal Pharmaceuticals Inc (MDGL) include a net purchase of 424,685 shares made by Baker Bros. Advisors Lp , a net sale of 12,736 shares made by Robert E. Waltermire , and a net sale of 100,000 shares made by Paul A Friedman .
In summary, during the past 3 months, insiders sold 6,363 shares of Madrigal Pharmaceuticals Inc (MDGL) in total and bought 0 shares, with a net sale of 6,363 shares. During the past 18 months, 303,930 shares of Madrigal Pharmaceuticals Inc (MDGL) were sold and 424,685 shares were bought by its insiders, resulting in a net purchase of 120,755 shares.
Madrigal Pharmaceuticals Inc (MDGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Madrigal Pharmaceuticals Inc Insider Transactions
Jeremy G Chadwick Mailing Address
Above is the net worth, insider trading, and ownership report for Jeremy G Chadwick. You might contact Jeremy G Chadwick via mailing address: C/o Kymera Therapeutics, Inc., 200 Arsenal Yards Blvd., Suite 230, Watertown Ma 02472.